TickerFactsScreenerDevelopers

ELITE PHARMACEUTICALS INC /NV/ (ELTP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $578.2K2011: $1.83M2012: $668.4K2013: $369.0K2014: $6.94M2015: $7.46M2016: $11.51M2017: $10.59M2018: $7.18M2019: $2.28M2020: $1.13M2021: $3.19M2022: $8.54M2023: $7.83M2024: $7.11M$7.11M
2010Cash & Equivalents (USD)2024
Fiscal YearCash & EquivalentsChange YoY
2024$7.11M-9.3%
2023$7.83M-8.2%
2022$8.54M+167.3%
2021$3.19M+182.1%
2020$1.13M-50.3%
2019$2.28M-68.3%
2018$7.18M-32.2%
2017$10.59M-8.0%
2016$11.51M+54.2%
2015$7.46M+7.5%
2014$6.94M+1781.1%
2013$369.0K-44.8%
2012$668.4K-63.4%
2011$1.83M+215.8%
2010$578.2K—